BNP Paribas Financial Markets
IPSC icon

BNP Paribas Financial Markets’s Century Therapeutics IPSC Stock Holding History

BNP Paribas Financial Markets’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.6K Buy
25,563
+24,145
+1,703% +$55.2K ﹤0.01% 4782
2026
Q1 		$3.21K Sell
1,418
-29
-2% -$61 ﹤0.01% 5372
2025
Q4 		$1.44K Sell
1,447
-31
-2% -$19 ﹤0.01% 5372
2025
Q3 		$736 Sell
1,478
-2,203
-60% -$1.19K ﹤0.01% 5268
2025
Q2 		$2.06K Sell
3,681
-601
-14% -$322 ﹤0.01% 5053
2025
Q1 		$2.04K Sell
4,282
-5,510
-56% -$4.14K ﹤0.01% 4982
2024
Q4 		$9.89K Buy
+9,792
New +$13.3K ﹤0.01% 4844

Other funds holding IPSC

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BNP Paribas Financial Markets's IPSC Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Century Therapeutics (IPSC) stake by 1,703% in Q2 2026, buying an estimated $55.2K and bringing the position to 25,563 shares worth $62.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4782.

BNP Paribas Financial Markets first reported a position in IPSC in Q4 2024 and has held it in 7 quarters since. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • BNP Paribas Financial Markets held 25,563 shares of Century Therapeutics worth $62.6K as of Q2 2026.
  • BNP Paribas Financial Markets bought 24,145 Century Therapeutics shares in Q2 2026, an estimated $55.2K.
  • Century Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4782 holding.
  • BNP Paribas Financial Markets first reported a position in Century Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.